February 7, 2023
Benzinga
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
BENSALEM, Pa. , Feb. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors ... See more »
Cancer Therapeutics CRC : Australia's CTx in up to $460 million deal with Pfizer on novel cancer drugs
Melbourne, Australia-headquartered Cancer Therapeutics CRC (CTx) has announced a two-year research collaboration...
Read full article »
February 6, 2023
Pharmabiz
Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx
Novartis announced that The Lancet has published long-term data from the pivotal SUNSHINE and SUNRISE... See more »
February 7, 2023
Benzinga
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
BENSALEM, Pa. , Feb. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors ... See more »
February 6, 2023
Pharmabiz
Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx
Novartis announced that The Lancet has published long-term data from the pivotal SUNSHINE and SUNRISE... See more »
CEO
Cancer Therapeutics CRC is a biotechnology company that develops new drugs for cancer treatment.
Read more